
|Videos|May 5, 2017
High Cost Drug Launches in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.
Advertisement
Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bipartisan Legislation Introduced to Control Drug Prices, ‘Corporate Greed’ Within Health Care
2
FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products
3
FDA Approves Drug Labeling Changes to 6 Menopausal Hormone Therapy Products
4
Trispecific Antibody IBI3003 Receives Fast Track Designation for Relapsed or Refractory Multiple Myeloma
5








































